Inmunotek S.l.

This study tested whether a bacterial vaccine called MV130, taken daily under the tongue for 12 months, could reduce the number and severity of flare-ups in adults with moderate to severe COPD. Researchers compared it to a placebo in 198 participants and followed them for 18 mont…

This study tested an immunotherapy treatment (Clustoid® Max Forte) for people with dust mite allergies, including those with allergic rhinitis, asthma, or eye allergies. Researchers looked at 140 patients aged 5 to 65 who had been on the treatment for at least a year. They measur…